Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arndt Hartmann

Showing results (671-680 of 933) with videos related to

Pageof 94
Sort By:
The American Journal of Surgical Pathology|May 29, 2007
Low frequency of molecular changes and tumor recurrence in inverted papillomas of the urinary tractMatthias Eiber, Johanna M M van Oers, Ellen C Zwarthoff, et al.
Journal of Cancer Research and Clinical Oncology|December 5, 2022
Exceptional response to neoadjuvant targeted therapy with the selective RET inhibitor selpercatinib in RET-fusion-associated sarcomaKarin G Schrenk, Wolfram Weschenfelder, Christian Spiegel, et al.
Frontiers in Oncology|May 16, 2022
Glucose-Restricted Diet Regulates the Tumor Immune Microenvironment and Prevents Tumor Growth in Lung AdenocarcinomaAlexander Gähler, Denis I Trufa, Mircea T Chiriac, et al.
European Urology Focus|February 18, 2018
Metabolic and Lipidomic Reprogramming in Renal Cell Carcinoma Subtypes Reflects Regions of Tumor OriginElke Schaeffeler, Florian Büttner, Anna Reustle, et al.
BMC Cancer|October 31, 2018
Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancerPaul Gass, Michael P Lux, Claudia Rauh, et al.
The American Journal of Surgical Pathology|May 16, 2022
Recurrent KAT6B/A::KANSL1 Fusions Characterize a Potentially Aggressive Uterine Sarcoma Morphologically Overlapping With Low-grade Endometrial Stromal SarcomaAbbas Agaimy, Blaise A Clarke, David L Kolin, et al.
Cancers|October 13, 2021
<i>MET</i> Amplification in Non-Small Cell Lung Cancer (NSCLC)-A Consecutive Evaluation Using Next-Generation Sequencing (NGS) in a Real-World SettingChristoph Schubart, Robert Stöhr, Lars Tögel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
Loss of p16 protein defines high-risk patients with gastrointestinal stromal tumors: a tissue microarray studyRegine Schneider-Stock, Carsten Boltze, Jerzy Lasota, et al.
The American Journal of Surgical Pathology|May 17, 2019
Nuclear NR4A3 Immunostaining Is a Specific and Sensitive Novel Marker for Acinic Cell Carcinoma of the Salivary GlandsFlorian Haller, Alena Skálová, Stephan Ihrler, et al.
Human Pathology|June 10, 2018
Micropapillary urothelial carcinoma: evaluation of HER2 status and immunohistochemical characterization of the molecular subtypeUlrike Zinnall, Veronika Weyerer, Eva Compérat, et al.
Pageof 94

Showing results (671-680 of 933) with videos related to

Sort By:
Pageof 94
The American Journal of Surgical Pathology|May 29, 2007
Low frequency of molecular changes and tumor recurrence in inverted papillomas of the urinary tractMatthias Eiber, Johanna M M van Oers, Ellen C Zwarthoff, et al.
Journal of Cancer Research and Clinical Oncology|December 5, 2022
Exceptional response to neoadjuvant targeted therapy with the selective RET inhibitor selpercatinib in RET-fusion-associated sarcomaKarin G Schrenk, Wolfram Weschenfelder, Christian Spiegel, et al.
Frontiers in Oncology|May 16, 2022
Glucose-Restricted Diet Regulates the Tumor Immune Microenvironment and Prevents Tumor Growth in Lung AdenocarcinomaAlexander Gähler, Denis I Trufa, Mircea T Chiriac, et al.
European Urology Focus|February 18, 2018
Metabolic and Lipidomic Reprogramming in Renal Cell Carcinoma Subtypes Reflects Regions of Tumor OriginElke Schaeffeler, Florian Büttner, Anna Reustle, et al.
BMC Cancer|October 31, 2018
Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancerPaul Gass, Michael P Lux, Claudia Rauh, et al.
The American Journal of Surgical Pathology|May 16, 2022
Recurrent KAT6B/A::KANSL1 Fusions Characterize a Potentially Aggressive Uterine Sarcoma Morphologically Overlapping With Low-grade Endometrial Stromal SarcomaAbbas Agaimy, Blaise A Clarke, David L Kolin, et al.
Cancers|October 13, 2021
<i>MET</i> Amplification in Non-Small Cell Lung Cancer (NSCLC)-A Consecutive Evaluation Using Next-Generation Sequencing (NGS) in a Real-World SettingChristoph Schubart, Robert Stöhr, Lars Tögel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
Loss of p16 protein defines high-risk patients with gastrointestinal stromal tumors: a tissue microarray studyRegine Schneider-Stock, Carsten Boltze, Jerzy Lasota, et al.
The American Journal of Surgical Pathology|May 17, 2019
Nuclear NR4A3 Immunostaining Is a Specific and Sensitive Novel Marker for Acinic Cell Carcinoma of the Salivary GlandsFlorian Haller, Alena Skálová, Stephan Ihrler, et al.
Human Pathology|June 10, 2018
Micropapillary urothelial carcinoma: evaluation of HER2 status and immunohistochemical characterization of the molecular subtypeUlrike Zinnall, Veronika Weyerer, Eva Compérat, et al.
Pageof 94